FDA bends rules on experimental AIDS drug.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D004338:Drug Combinations / Q000627:therapeutic use; D005965:Glucuronates / Q000627:therapeutic use*; D006291:Health Policy; D006801:Humans; D011634:Public Health / Q000331:legislation & jurisprudence*; D011799:Quinazolines / Q000627:therapeutic use*; D016597:Trimetrexate / Q000031:analogs & derivatives*; D014481:United States; D014486:United States Food and Drug Administration
D004338:Drug Combinations; D005965:Glucuronates; D011799:Quinazolines; C056321:trimetrexate glucuronate; D016597:Trimetrexate